316 related articles for article (PubMed ID: 29093475)
1. HSP90 recognizes the N-terminus of huntingtin involved in regulation of huntingtin aggregation by USP19.
He WT; Xue W; Gao YG; Hong JY; Yue HW; Jiang LL; Hu HY
Sci Rep; 2017 Nov; 7(1):14797. PubMed ID: 29093475
[TBL] [Abstract][Full Text] [Related]
2. Cytoplasmic Ubiquitin-Specific Protease 19 (USP19) Modulates Aggregation of Polyglutamine-Expanded Ataxin-3 and Huntingtin through the HSP90 Chaperone.
He WT; Zheng XM; Zhang YH; Gao YG; Song AX; van der Goot FG; Hu HY
PLoS One; 2016; 11(1):e0147515. PubMed ID: 26808260
[TBL] [Abstract][Full Text] [Related]
3. Domain interactions reveal auto-inhibition of the deubiquitinating enzyme USP19 and its activation by HSP90 in the modulation of huntingtin aggregation.
Xue W; Zhang SX; He WT; Hong JY; Jiang LL; Hu HY
Biochem J; 2020 Nov; 477(21):4295-4312. PubMed ID: 33094816
[TBL] [Abstract][Full Text] [Related]
4. Aggregation landscapes of Huntingtin exon 1 protein fragments and the critical repeat length for the onset of Huntington's disease.
Chen M; Wolynes PG
Proc Natl Acad Sci U S A; 2017 Apr; 114(17):4406-4411. PubMed ID: 28400517
[TBL] [Abstract][Full Text] [Related]
5. The interaction between RE1-silencing transcription factor (REST) and heat shock protein 90 as new therapeutic target against Huntington's disease.
Orozco-Díaz R; Sánchez-Álvarez A; Hernández-Hernández JM; Tapia-Ramírez J
PLoS One; 2019; 14(7):e0220393. PubMed ID: 31361762
[TBL] [Abstract][Full Text] [Related]
6. Pathological polyQ expansion does not alter the conformation of the Huntingtin-HAP40 complex.
Huang B; Guo Q; Niedermeier ML; Cheng J; Engler T; Maurer M; Pautsch A; Baumeister W; Stengel F; Kochanek S; Fernández-Busnadiego R
Structure; 2021 Aug; 29(8):804-809.e5. PubMed ID: 33909994
[TBL] [Abstract][Full Text] [Related]
7. N-Terminal Fragments of Huntingtin Longer than Residue 170 form Visible Aggregates Independently to Polyglutamine Expansion.
Chen MZ; Mok SA; Ormsby AR; Muchowski PJ; Hatters DM
J Huntingtons Dis; 2017; 6(1):79-91. PubMed ID: 28339398
[TBL] [Abstract][Full Text] [Related]
8. The 17-residue-long N terminus in huntingtin controls stepwise aggregation in solution and on membranes via different mechanisms.
Pandey NK; Isas JM; Rawat A; Lee RV; Langen J; Pandey P; Langen R
J Biol Chem; 2018 Feb; 293(7):2597-2605. PubMed ID: 29282287
[TBL] [Abstract][Full Text] [Related]
9. Herp Promotes Degradation of Mutant Huntingtin: Involvement of the Proteasome and Molecular Chaperones.
Luo H; Cao L; Liang X; Du A; Peng T; Li H
Mol Neurobiol; 2018 Oct; 55(10):7652-7668. PubMed ID: 29430620
[TBL] [Abstract][Full Text] [Related]
10. N-terminal Huntingtin Knock-In Mice: Implications of Removing the N-terminal Region of Huntingtin for Therapy.
Liu X; Wang CE; Hong Y; Zhao T; Wang G; Gaertig MA; Sun M; Li S; Li XJ
PLoS Genet; 2016 May; 12(5):e1006083. PubMed ID: 27203582
[TBL] [Abstract][Full Text] [Related]
11. The Polyglutamine Expansion at the N-Terminal of Huntingtin Protein Modulates the Dynamic Configuration and Phosphorylation of the C-Terminal HEAT Domain.
Jung T; Shin B; Tamo G; Kim H; Vijayvargia R; Leitner A; Marcaida MJ; Astorga-Wells J; Jung R; Aebersold R; Peraro MD; Hebert H; Seong IS; Song JJ
Structure; 2020 Sep; 28(9):1035-1050.e8. PubMed ID: 32668197
[TBL] [Abstract][Full Text] [Related]
12. Modulation of mutant Huntingtin aggregates and toxicity by human myeloid leukemia factors.
Banerjee M; Datta M; Bhattacharyya NP
Int J Biochem Cell Biol; 2017 Jan; 82():1-9. PubMed ID: 27840155
[TBL] [Abstract][Full Text] [Related]
13. SUMOylation Prevents Huntingtin Fibrillization and Localization onto Lipid Membranes.
Sedighi F; Adegbuyiro A; Legleiter J
ACS Chem Neurosci; 2020 Feb; 11(3):328-343. PubMed ID: 31880908
[TBL] [Abstract][Full Text] [Related]
14. Exploding the Repeat Length Paradigm while Exploring Amyloid Toxicity in Huntington's Disease.
Wetzel R
Acc Chem Res; 2020 Oct; 53(10):2347-2357. PubMed ID: 32975927
[TBL] [Abstract][Full Text] [Related]
15. Biophysical Aspect of Huntingtin Protein During polyQ: An In Silico Insight.
Gopalakrishnan C; Jethi S; Kalsi N; Purohit R
Cell Biochem Biophys; 2016 Jun; 74(2):129-39. PubMed ID: 27094178
[TBL] [Abstract][Full Text] [Related]
16. Generation and Characterization of Knock-in Mouse Models Expressing Versions of Huntingtin with Either an N17 or a Combined PolyQ and Proline-Rich Region Deletion.
André EA; Braatz EM; Liu JP; Zeitlin SO
J Huntingtons Dis; 2017; 6(1):47-62. PubMed ID: 28211815
[TBL] [Abstract][Full Text] [Related]
17. Cholesterol impacts the formation of huntingtin/lipid complexes and subsequent aggregation.
Stonebraker AR; Beasley M; Massinople S; Wunder M; Li P; Valentine SJ; Legleiter J
Protein Sci; 2023 May; 32(5):e4642. PubMed ID: 37052951
[TBL] [Abstract][Full Text] [Related]
18. Proteostasis of Huntingtin in Health and Disease.
Koyuncu S; Fatima A; Gutierrez-Garcia R; Vilchez D
Int J Mol Sci; 2017 Jul; 18(7):. PubMed ID: 28753941
[TBL] [Abstract][Full Text] [Related]
19. Structural insights into the aggregation mechanism of huntingtin exon 1 protein fragment with different polyQ-lengths.
Priya SB; Gromiha MM
J Cell Biochem; 2019 Jun; 120(6):10519-10529. PubMed ID: 30672003
[TBL] [Abstract][Full Text] [Related]
20. Acetylation within the First 17 Residues of Huntingtin Exon 1 Alters Aggregation and Lipid Binding.
Chaibva M; Jawahery S; Pilkington AW; Arndt JR; Sarver O; Valentine S; Matysiak S; Legleiter J
Biophys J; 2016 Jul; 111(2):349-362. PubMed ID: 27463137
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
